These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16918462)

  • 1. Design and synthesis of phosphonodifluoromethyl phenylalanine (F2Pmp): a useful phosphotyrosyl mimetic.
    Burke TR
    Curr Top Med Chem; 2006; 6(14):1465-71. PubMed ID: 16918462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of phosphotyrosyl mimetic 4-(phosphonodifluoromethyl)phenylalanine (F2Pmp) into signal transduction-directed peptides.
    Yao ZJ; Lee K; Burke TR
    Methods Mol Biol; 2005; 298():91-103. PubMed ID: 16044542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
    Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
    J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.
    Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y
    Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases?
    Chen L; Wu L; Otaka A; Smyth MS; Roller PP; Burke TR; den Hertog J; Zhang ZY
    Biochem Biophys Res Commun; 1995 Nov; 216(3):976-84. PubMed ID: 7488220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp.
    Burke TR; Kole HK; Roller PP
    Biochem Biophys Res Commun; 1994 Oct; 204(1):129-34. PubMed ID: 7524496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors.
    Burke TR; Smyth MS; Otaka A; Nomizu M; Roller PP; Wolf G; Case R; Shoelson SE
    Biochemistry; 1994 May; 33(21):6490-4. PubMed ID: 7515682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides.
    Burke TR; Ye B; Akamatsu M; Ford H; Yan X; Kole HK; Wolf G; Shoelson SE; Roller PP
    J Med Chem; 1996 Mar; 39(5):1021-7. PubMed ID: 8676336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphotyrosyl mimetics in the development of signal transduction inhibitors.
    Burke TR; Lee K
    Acc Chem Res; 2003 Jun; 36(6):426-33. PubMed ID: 12809529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide probes containing a non-hydrolyzable phosphotyrosine-mimetic residue for enrichment of protein tyrosine phosphatases.
    Tsumagari K; Niinae T; Otaka A; Ishihama Y
    Proteomics; 2022 Feb; 22(4):e2100144. PubMed ID: 34714599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands. 2. 4-(2-Malonyl)phenylalanine as a potent phosphotyrosyl mimetic.
    Gao Y; Luo J; Yao ZJ; Guo R; Zou H; Kelley J; Voigt JH; Yang D; Burke TR
    J Med Chem; 2000 Mar; 43(5):911-20. PubMed ID: 10715157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of a beta-amino phosphotyrosyl mimetic suitably protected for peptide synthesis.
    Lee K; Zhang M; Yang D; Burke TR
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3399-401. PubMed ID: 12419370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Novel Phosphonodifluoromethyl-Containing Phosphotyrosine Mimetics and a First-In-Class, Potent, Selective, and Bioavailable Inhibitor of Human CDC14 Phosphatases.
    Dong J; Jassim BA; Milholland KL; Qu Z; Bai Y; Miao Y; Miao J; Ma Y; Lin J; Hall MC; Zhang ZY
    J Med Chem; 2024 Jun; 67(11):8817-8835. PubMed ID: 38768084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
    Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
    J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of 4-(alpha-hydroxymalonyl)phenylalanine as a new phosphotyrosyl mimetic and its use in growth factor receptor bound 2 src-homology 2 (Grb2 SH2) domain-binding peptides.
    Kang SU; Worthy KM; Bindu LK; Zhang M; Yang D; Fisher RJ; Burke TR
    J Med Chem; 2005 Aug; 48(16):5369-72. PubMed ID: 16078854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics.
    Oishi S; Karki RG; Kang SU; Wang X; Worthy KM; Bindu LK; Nicklaus MC; Fisher RJ; Burke TR
    J Med Chem; 2005 Feb; 48(3):764-72. PubMed ID: 15689160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New syntheses of tetrazolylmethylphenylalanine and O-malonyltyrosine as pTyr mimetics for the design of STAT3 dimerization inhibitors.
    Dourlat J; Valentin B; Liu WQ; Garbay C
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3943-6. PubMed ID: 17509878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise and enantioselective synthesis of Fmoc-Pmp(But)2-OH and design of potent Pmp-containing Grb2-SH2 domain antagonists.
    Li P; Zhang M; Peach ML; Liu H; Yang D; Roller PP
    Org Lett; 2003 Aug; 5(17):3095-8. PubMed ID: 12916990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution structure of the Yersinia pestis protein tyrosine phosphatase YopH in complex with a phosphotyrosyl mimetic-containing hexapeptide.
    Phan J; Lee K; Cherry S; Tropea JE; Burke TR; Waugh DS
    Biochemistry; 2003 Nov; 42(45):13113-21. PubMed ID: 14609321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics.
    Groves MR; Yao ZJ; Roller PP; Burke TR; Barford D
    Biochemistry; 1998 Dec; 37(51):17773-83. PubMed ID: 9922143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.